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Abstract
Background
The development of new diagnostics is an important tool in the fight against disease. Latent
Class Analysis (LCA) is used to estimate the sensitivity and specificity of tests in the
absence of a gold standard. The main field diagnostic for Schistosoma mansoni infection,
Kato-Katz (KK), is not very sensitive at low infection intensities. A point-of-care circulating
cathodic antigen (CCA) test has been shown to be more sensitive than KK. However, CCA
can return an ambiguous ‘trace’ result between ‘positive’ and ‘negative’, and much debate
has focused on interpretation of traces results.
Methodology/Principle findings
We show how LCA can be extended to include ambiguous trace results and analyse S.
mansoni studies from both Coˆte d’Ivoire (CdI) and Uganda. We compare the diagnostic per-
formance of KK and CCA and the observed results by each test to the estimated infection
prevalence in the population.
Prevalence by KK was higher in CdI (13.4%) than in Uganda (6.1%), but prevalence by
CCA was similar between countries, both when trace was assumed to be negative (CCAtn:
11.7% in CdI and 9.7% in Uganda) and positive (CCAtp: 20.1% in CdI and 22.5% in
Uganda). The estimated sensitivity of CCA was more consistent between countries than the
estimated sensitivity of KK, and estimated infection prevalence did not significantly differ
between CdI (20.5%) and Uganda (19.1%). The prevalence by CCA with trace as positive
did not differ significantly from estimates of infection prevalence in either country, whereas
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both KK and CCA with trace as negative significantly underestimated infection prevalence in
both countries.
Conclusions
Incorporation of ambiguous results into an LCA enables the effect of different treatment
thresholds to be directly assessed and is applicable in many fields. Our results showed that
CCA with trace as positive most accurately estimated infection prevalence.
Author summary
Schistosomiasis is a debilitating disease affecting over 200 million people worldwide,
mainly in developing countries. Treatment for schistosomiasis is straightforward and
involves treating all school-age children, and sometimes also adults, in areas where schis-
tosomiasis is known to occur. However, detecting intestinal schistosomiasis (Schistosoma
mansoni) using Kato-Katz, the most common technique, can fail to detect infection when
it is present as Kato-Katz relies on finding eggs within a small stool sample. A new field
diagnostic, CCA, is promising as it is simple to use and seems to detect more infections
that Kato-Katz. However, assessing the performance of CCA is difficult as we cannot be
certain whether or not those positive by CCA but negative by Kato-Katz are truly infected.
Additionally, CCA can often return a trace result between negative and positive which is
difficult to interpret. We assess the performance of Kato-Katz and CCA in both Coˆte
d’Ivoire and Uganda. We showed that CCA did indeed detect more infections than Kato-
Katz, and that CCA accurately estimated the proportion of people truly infected in the
population, when trace readings were considered positive. CCA is consequently an impor-
tant and valuable tool in the fight against schistosomiasis.
Introduction
It is estimated that 237 million individuals require treatment for schistosomiasis [1]. Endemic
in 56 countries spanning over Africa, the Middle East, South America, and the West Indies,
Schistosoma mansoni is the most geographically widespread schistosome species. Nevertheless,
despite a growing body of studies looking at distribution (e.g. [2–4]), we do not have a true
representation of the number of people infected with S. mansoni as there is no definitive ‘gold
standard’ field diagnostic test. Accurate prevalence estimates of those infected are important,
as even low infection intensities have associated morbidity [5]. The current recommended
control method for schistosomiasis is preventive chemotherapy (PC) of at-risk populations,
where all school-aged children (SAC) and, where appropriate, at-risk adults in the community
are treated. Frequency of treatment and who receives the drugs are dependent on the preva-
lence of schistosomiasis in the local area [6], as determined by the parasitological diagnostic
test Kato-Katz, where eggs are detected in faecal samples examined microscopically [7, 8].
Kato-Katz has low sensitivity in those with low infection intensities and in areas of low preva-
lence, as egg output varies both within and between days [9] and infection can easily be missed
[10]. However, Kato-Katz is highly specific, as an S. mansoni egg is easily identifiable to a
trained technician [11].
A rapid diagnostic test, Circulating Cathodic Antigen (CCA), has recently been endorsed
by the World Health Organisation (WHO) for use in mapping and programme impact
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evaluation [12]. CCA uses a urine sample to test for S. mansoni infection and consequently is
much simpler to use than Kato-Katz. However, the presence of an ambiguous result between
negative and positive, known as a ‘trace’ result, complicates the interpretation of a CCA test.
There is no consensus in the literature on whether trace should be considered as positive or
negative (e.g. trace as negative as found to be closest to Kato-Katz:[13], trace assumed to be
negative: [14], trace assumed to be positive: [11], [15]). Additionally, it is not clear how to
interpret prevalence estimates from CCA tests and whether or not they are reflective of infec-
tion prevalence in the population.
Latent Class Analysis (LCA) estimates the sensitivity and specificity of diagnostic tests and
the prevalence in the population in the absence of a gold standard, and has been applied in a
wide range of fields including human soil transmitted helminthiases [16], malaria [17], and
veterinary biology [18]. Analysis of LCA can be within a frequentist or Bayesian framework,
with the Bayesian approach having several advantages. Firstly, the distribution of additional
parameters such as Positive and Negative Predictive Values (PPV and NPV respectively) are
easily calculated from the posterior distributions obtained from the LCA, which enables the
results to be more easily interpreted. Secondly, Bayesian analysis enables straightforward com-
parison of estimated infection prevalence and the prevalence by each test to assess how well
the test performs in estimating prevalence rather than infection status of each individual.
Finally, the use of posterior distributions enables straightforward testing of differences
between countries and between tests.
The aim of this study is to robustly analyse CCA data from two countries, Coˆte d’Ivoire and
Uganda, to determine the effects of considering CCA trace as negative or positive. We particu-
larly focus on assessing the performance of CCA and Kato-Katz at measuring ‘infection preva-
lence’, which is estimated from the LCA, and is the main use of S. mansoni diagnostics in
control programs.
Methods
Ethics statement
Ethical approval for both surveys, including the consent process, was obtained from Imperial
College Research Ethics Committee (ICREC_8_2_2) as well as from the appropriate country:
Comite´ National d’Ethique de la Recherche (CNER; ref: 086/MSHP/CNER-kp) in Coˆte
d’Ivoire and Uganda National Council for Science and Technology (UNCST; ref: HS1993) in
Uganda.
The surveys were undertaken as part of the national schistosomiasis control programmes in
each country, overseen and approved by the relevant Ministries of Health. As participants
were under 18 years of age, written consent was required by a parent or informed guardian.
Head-teachers in each school acted as the informed guardian as literacy levels in many areas
are low. The head-teacher was informed fully about the study and requested to provide
informed consent for field teams to collect urine and stool samples from pupils. Only children
who consented orally both before and after selection in the presence of a witness (head-
teacher) took part in the survey. Additionally, all children gave urine and stool samples freely
following selection, and there were no consequences if a child did not return their samples. All
data were entered and analysed anonymously.
Data collection
Overall summary. Data were collected as part of the programme Monitoring and Evalua-
tion activities within each country. Samples were collected as part of a Monitoring & Evalua-
tion impact study, in which a consistent age range of children in a set of schools (sentinel sites)
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are screened for schistosomiasis over multiple years to estimate changes in prevalence and
intensity of infection over time. In Coˆte d’Ivoire data collected in 2013 were ‘baseline’ data,
that is, data collected in the first year of the control programme prior to mass treatment with
Praziquantel. In contrast, Uganda established a national schistosomiasis control programme
in 2003 and had received at least four rounds of PC prior to the survey in 2013. In addition,
schools selected in Uganda were part of an operational research project where three different
treatment strategies in years following the baseline survey were randomly allocated to each of
the schools. Data were collected between 28th October– 12th November 2013 in Coˆte d’Ivoire
and between 30th September– 16th October 2013 in Uganda. Full study protocols are available
on request from the Schistosomiasis Control Initiative, Imperial College London.
Selection of schools. Data were collected in 26 schools across 10 districts in Coˆte d’Ivoire
and in 14 schools across four districts in Uganda. The surveyed schools were randomly
selected from the sampling frame in each country.
In Coˆte d’Ivoire, all schools in the baseline survey were tested with both CCA and Kato-
Katz, and the sample size calculation was powered to be able to detect change in prevalence
between the baseline and repeat surveys using Kato-Katz and not for the purposes of diagnos-
tic comparison. In Coˆte d’Ivoire the sampling frame was all schools involved in a baseline
schistosomiasis mapping survey in 2012 where at least one child infected with S. mansoni was
observed during mapping, within districts that fell into moderate ( 10% and<50% preva-
lence by Kato-Katz) or high ( 50% prevalence by Kato-Katz) prevalence categories by WHO
guidelines [19]. Mapped schools were used in the site selection as no treatment had occurred
in these schools post-mapping.
In Uganda, 120 schools were selected to be were sampled using CCA only, with 40 schools
being in each of three treatments arms, although in the field only 119 schools were sampled. A
subset of 14 schools (planned to be 15) were sampled using both CCA and Kato-Katz to obtain
a pre-determined sample size of approximately 300 pupils in each treatment arm to enable
comparison of test results using LCA; here we focus on the 14 schools only. The sampling
frame for Uganda was a list of all mixed-sex primary schools with at least 100 pupils in ‘low
endemic’ sub districts from the 2012 CCA mapping exercise in Uganda, that had received at
least four rounds of praziquantel treatment. Schools that were mapped as part of the recent
mapping exercise where no schistosomiasis was found with CCA were excluded from the sam-
pling frame and ‘low endemic’ was defined as those subcounties with equivalent to less than
10% S. mansoni prevalence by Kato-Katz, back calculated as 1–46% by CCA [20].
Selection of children within schools. In Coˆte d’Ivoire, 125 children per school from clas-
ses CP1, CP2 and CE1 (roughly equivalent to 6, 7 and 8-year-olds) were targeted for sampling.
In Uganda, 60 students were targeted in each school although sampling of children by grades
was not consistent. Nine schools sampled children in primary classes 1, 4, 5 and 6 (roughly
equivalent to 6, 9, 10 and 11-year-olds) as per the sampling protocol and five schools deviated
from the sampling protocol by sampling children in grades 1, 3, 5 and 7 (roughly equivalent to
6, 8, 10 and 12-year-olds). In both countries, equal number of boys and girls were randomly
sampled within each school, selection of pupils within each class and sex was random, and
there was no reference to possible infection status during selection. There was no treatment of
the children during the surveys as treatment was part of the wider school-based PC treatment
administered by the national programs following the surveys whereby all children were treated
regardless of infection status.
Parasitological variables. Duplicate Kato-Katz thick smear slides per stool sample (using
41.7 mg template) were prepared and examined for S. mansoni using WHO approved standard
operating procedures on each of two and three consecutive days in Coˆte d’Ivoire and Uganda,
respectively. To provide a like-for-like comparison, we included data collected on only the first
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two days from Uganda in results presented here. A child was defined to be positive by Kato-
Katz if one or more S. mansoni eggs were found on any of the four slides examined, and mean
infection intensity in eggs per gram (epg) was calculated by multiplying the average number of
eggs found across all examined slides by 24.
CCA data were collected on the first day of the survey in Coˆte d’Ivoire and on all three days
in Uganda; for comparison purposes only CCA results from the first day of data collection
have been assessed in both countries. CCA results were scored on a four-point scale in Coˆte
d’Ivoire and a five-point scale in Uganda, with 0 denoting negative and the lowest positive
score denoting trace, as per manufacturers recommendation, in both countries. A child was
defined to be positive by CCA with trace assumed negative (CCAtn) if the CCA result was
greater than trace in either country, and positive by CCA with trace assumed positive (CCAtp)
if the CCA result was greater than or equal to trace in either country. Only children with four
slides of Kato-Katz (two slides on each of two days) and one CCA result were included in the
analyses.
Quality control was assured through rigorous training before the field survey and quality
checks during the field survey. In Coˆte d’Ivoire, each Kato-Katz slide was read independently
by two slide technicians, and any differences greater than 10% were reread by a third person to
determine the correct egg count. Additionally, 10% of the slides were checked for quality con-
trol, and the CCA readings were always read by the same person to ensure consistency across
time. In Uganda, an experienced technician rescored at least 10% of all Kato-Katz slides, and
independently performed CCA tests on at least 10% of all urine samples. Kato-Katz and CCA
test processing was performed by the same survey team members in each school. The tests
were numbered and the Kato-Katz and CCA tests were processed separately. Consequently,
clinical information and other tests results were not available to the field team during test pro-
cessing. Testing required only urine and stool samples from each child and no adverse effects
from performing either test were observed.
Statistical analysis
Latent class analysis. Analysis of the test results was by Bayesian LCA. Full details of the
methodology are available in the S1 Supporting Information and consequently we focus on the
main points here. All analyses were pre-specified. LCA estimates the sensitivity and specificity
of each test and the prevalence in the population. Sensitivity is defined as the proportion of
people truly positive testing positive and specificity is defined as the proportion of people truly
negative testing negative, with high values of both parameters being desirable.
The LCA firstly involves calculating the number of people with each possible test combina-
tion, which is then related to the sensitivity and specificity of each test and the prevalence,
using likelihood functions. For example, the number of people testing positive on two tests can
be split into two groups–those who are truly positive (with prevalence being the proportion of
individuals in this group) and correctly test positive on both tests (related to the sensitivities of
the tests), and those who are truly negative and incorrectly test positive on both tests (related
to the specificities of the tests); see S1 Supporting Information for full explanation and equa-
tions). Similar logic can be used for each possible test combination and these equations are
then tied to the observed numbers using a multinomial distribution.
The simplest form of LCA assumes that tests are independent conditional on true infection
status. That is, within each group of positive or negative people, knowing the results of one test
does not allow you to predict the results of any other test. This can be violated if, for example,
people who are heavily infected are more likely to test positive on both tests than those who
are lightly infected. Dendukuri and Joseph, 2001 [21], proposed an extension to the basic LCA
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where covariance terms are added and, in a Bayesian framework, limits are placed on the prior
distributions so that proportions are always between zero and one.
Incorporating trace results into the model requires adding an additional result to the positive
or negative normally assumed for each test. However, there is also an important insight required
to construct the likelihood functions. Taking CCA trace as positive (CCAtp) will lead to more
people being positive than when trace is negative (CCAtn). If at least one of these trace results is
truly positive then the sensitivity of CCAtp will be more than the sensitivity of CCAtn, and if at
least one of these trace results is truly negative then the specificity of CCAtp will be less than the
specificity of CCAtn. We can combine the above to give the following likelihood equations:
pþþ ¼ prev  ðSe1  Se2 þ covSe1;2Þ þ ð1   prevÞ  ðð1   Sp1Þ  ð1   Sp2Þ þ covSp1;2Þ ð1Þ
pþt ¼ prev  ðSe1  adjSe2þcovSe1;adjÞ þ ð1   prevÞ  ðð1   Sp1Þ  adjSp2þcovSp1;adjÞ ð2Þ
pþ  ¼ prev  ðSe1  ð1   ðSe2 þ adjSe2ÞÞ   ðcovSe1;2 þ covSe1;adjÞÞ þ ð1   prevÞ  ðð1   Sp1Þ
 ðSp2   adjSp2Þ   ðcovSp1;2   covSp1;adjÞÞ ð3Þ
p  þ ¼ prev  ðð1   Se1Þ  Se2   covSe1;2Þ þ ð1   prevÞ  ðSp1  ð1   Sp2Þ   covSp1;2Þ ð4Þ
p  t ¼ prev  ðð1   Se1Þ  adjSe2   covSe1;adjÞ þ ð1   prevÞ  ðSp1  adjSp2  covSp1;adjÞ ð5Þ
p    ¼ prev  ðð1   Se1Þ  ð1   ðSe2 þ adjSe2ÞÞ þ ðcovSe1;2 þ covSe1;adjÞÞ þ ð1   prevÞ  ðSp1
 ðSp2   adjSp2Þ þ ðcovSp1;2   covSp1;adjÞÞ ð6Þ
where pKC denotes the proportion of people with a given test combination for Kato-Katz (K)
and CCA (C)–with Kato-Katz results being positive (+) or negative (-) and CCA results being
positive (+), trace (t) or negative (-); Se1 Sp1, Se2 and Sp2 denote the sensitivity and specificity of
Kato-Katz and CCAtn respectively; adjSe2 and adjSp2 denotes how much more sensitive and
less specific, respectively, CCA becomes when trace is considered as positive rather than nega-
tive; and prev denotes the infection prevalence in the population. The sensitivity of CCAtp is
then equal to:
Se2 þ adjSe2 ð7Þ
and the specificity of CCAtp equals:
Sp2   adjSp2 ð8Þ
In a similar manner to Dendukuri and Joseph (2001), we place limits on the covariances:
ðSe1   1Þð1   Se2Þ  covSe1;2  minðSe1; Se2Þ   Se1  Se2 ð9Þ
ðSe1   1Þð1   SeadjÞ  covSe1;adj  minðSe1; adjSe2Þ   Se1  adjSe2 ð10Þ
  Se1  ðSe2 þ adjSe2Þ  covSe1;2 þ covSe1;adj
 minð1   Se1; 1   ðSe2 þ adjSe2ÞÞ   ð1   Se1Þ  ð1   ðSe2 þ adjSe2Þ ð11Þ
ðSp1   1Þð1   Sp2Þ  covSp1;2  minðSp1; Sp2Þ   Sp1  Sp2 ð12Þ
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ðSp1   1Þð1   adjSp2Þ  covSp1;adj  minðSp1; adjSp2Þ   Sp1  adjSp2 ð13Þ
ðSp1   1Þ  ð1   ðSp2   adjSp2ÞÞ  covSp1;2   covSp1;adj  minðSp1; Sp2   adjSp2Þ   Sp1  ðSp2   adjSp2Þ ð14Þ
and we also place limits on adjSe2 and adjSp2 so that the sensitivity and specificity of Se2 + adjSe2
and Sp2 − adjSp2 remain between 0 and 1:
0 adjSe2  1   Se2 ð15Þ
0 adjSp2  Sp2 ð16Þ
The data are then linked to Eqs 1–6 through a multinomial distribution where N is the total
number of people tested:
ðnþþ;nþt ; nþ  ; n  þ; n  t; n    Þ  Multinomialðpþþ;pþt; pþ  ; p  þ; p  t; p    ;NÞ ð17Þ
Running the LCA. The LCA described above was run in OpenBugs [22] using the R2Open-
Bugs package [23] in R version 3.2.2 [24]. Analysis was performed separately for each country,
taking each school to be a separate population [16]. Beta prior distributions were used for sensi-
tivities and specificities. We imposed the strongest prior distribution on the specificity of Kato-
Katz (Beta(α = 21.2, β = 2.06), which is equivalent to 95% certain greater than 80%, mode at
95%), as the presence of an egg confirms infection, and weaker prior distributions on all other
sensitivities and specificities. For the sensitivity of both Kato-Katz and CCAtn, we used a prior of
Beta(3.05, 1.15) which is equivalent to 95% certain bigger than 30% with a mode at 80%, and for
the specificity of CCAtn we used a prior of Beta(5.38, 1.49) which is equivalent to 95% certain
bigger than 50% with a mode at 90%. For covariances and adjusted values of CCA trace positive
sensitivity and specificity relative to CCA trace negative, we used uniform prior distributions on
the restricted values described above, to ensure proportions remained bounded between zero and
one, with the exception that all covariances were restricted to be positive. We incorporated the
limits on the sum of the covariances into the model by adding extra restrictions to the individual
covariances so that their sum was limited to the required amount. We ran three MCMC chains,
where the starting points were randomly sampled, for 3,000 iterations following a burn-in of
1,000 with a thin of 25, and checked for convergence between the chains using Gelman diagnos-
tics [25]. Following the recommendation of Collins and Huynh 2014 [26], we imposed the
restriction of sensitivity plus specificity of each test being greater than 1 to avoid issues associated
with label switching. The code for running the LCA is available in S2 Supporting Information.
Sensitivity and specificity of CCA with trace as positive were calculated for each of the 6,000
stored iterations so that the distribution of these metrics could be obtained. We compared the sen-
sitivities and specificities, both from different countries and different tests, by calculating the distri-
bution of the difference between the focal metrics for each of the 6,000 iterations and determining
if the estimate was significantly different from zero using the 95% Bayesian credible interval (BCI).
Infection prevalence, PPV and NPV. An estimate of infection prevalence was obtained
by averaging the estimated infection prevalence in each school, weighted for the number of
pupils within each school. This overall infection prevalence estimate was used to obtain distri-
butions for the probability of an individual testing positive being truly positive (positive pre-
dicted value; PPV) and the probability of an individual testing negative being truly negative
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(negative predicted value; NPV) using the standard equations below:
PPVi ¼
prev  Sei
prev  Sei þ ð1   prevÞ  ð1   SpiÞ
ð18Þ
NPVi ¼
ð1   prevÞ  Spi
prev  ð1   SeiÞ þ ð1   prevÞ  Spi
ð19Þ
where i denotes each separate test, and prev denotes the overall prevalence estimated above.
Comparison between infection and test prevalence. We obtained a distribution for test
prevalence for each test (KK, CCAtn and CCAtp) in two steps. Firstly, we obtained a distribu-
tion for the number of children positive within each school for each test by sampling 6,000
times (the number of iterations in the posterior distribution) from a Binomial distribution
with parameters n equal to the number of children tested within the school and p equal to the
observed prevalence by the focal test in the school. Secondly, we calculated overall test preva-
lence for each of the 6,000 iterations by summing the total number of children positive in each
school by the focal test and dividing by the total number of children tested. The difference
between infection and test prevalence was then calculated through simple subtraction on each
of the 6,000 iterations to obtain a distribution of the specified differences.
Results
Descriptive results
A total of 3,035 and 693 children were included in the analysis for Coˆte d’Ivoire and Uganda,
respectively (Table 1). Prevalence by Kato-Katz was higher in Coˆte d’Ivoire (13.4%) than in
Table 1. Summary statistics for Coˆte d’Ivoire and Uganda. KK denotes Kato-Katz.
Coˆte d’Ivoire Uganda
Number schools 26 14
Number pupils 3035 693
Number age missing 116 22
Mean age in years (±SD) 7.9 (±1.6) 9.9 (±2.6)
Age range in years 4–15 5–17
Number sex missing 0 0
Number female 1485 268
Proportion female 49% 39%
Prevalence by Kato-Katz 13.4% 6.1%
Prevalence by CCAtn 11.7% 9.7%
Prevalence by CCAtp 20.1% 22.5%
Mean epg by Kato-Katz (±SD) 26.9 (±167.1) 3.4 (±29.0)
Proportion of test combinations
KK Result CCA result Coˆte d’Ivoire Uganda
positive positive 6.5% 3.8%
positive trace 2.2% 0.9%
positive negative 4.7% 1.4%
negative positive 5.2% 5.9%
negative trace 6.2% 12.0%
negative negative 75.2% 76.0%
https://doi.org/10.1371/journal.pntd.0006102.t001
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Uganda (6.1%), with mean intensity of infection, among all children, being over seven-fold
higher in Coˆte d’Ivoire (26.8 eggs per gram (epg)) than in Uganda (3.4 epg; Table 1). However,
prevalence by CCA was similar in both countries, both when trace was assumed to be negative
(CCAtn prevalence 11.7% in Coˆte d’Ivoire and 9.7% in Uganda) and when trace was assumed
to be positive (CCAtp prevalence 20.1% in Coˆte d’Ivoire and 22.5% in Uganda; Table 1). A
completed STARD checklist and participant flow diagram are available in S3 and S4 Support-
ing Informations respectively and the raw data used for analyses are available in S5 (Coˆte
d’Ivoire) and S6 (Uganda) Supporting Informations.
In both countries, just over 75% of pupils were negative on both tests, and 6.5% of children
in Coˆte d’Ivoire and 3.8% of children in Uganda were positive on both tests (Table 1, Fig 1).
CCA sometimes failed to detect infection where eggs were found by Kato-Katz: 4.7% of pupils
in Coˆte d’Ivoire and 1.4% of pupils in Uganda had a negative CCA result but were positive by
Kato-Katz. Similarly, Kato-Katz sometimes failed to detect infections that were positive (not
trace) by CCA: 5.2% and 5.9% of pupils in Coˆte d’Ivoire and Uganda, respectively, tested posi-
tive for CCA but negative by Kato-Katz. Tables of CCA results split by Kato-Katz infection cat-
egory are available in S7 Supporting Information.
Latent class analysis
Estimates of parameters obtained from the Bayesian LCA (sensitivity and specificity of each
test and prevalence) with the associated BCI are available in Table 2, and Fig 2 shows the poste-
rior distributions of sensitivity and specificity of each test. Table 2 also shows parameters cal-
culated from the posterior distributions of the estimated parameters.
Fig 1. Bar chart showing the proportion of children tested in each country with specified test results. For
example, ‘pos/pos’ denotes the proportion of children in each country testing positive for both tests, and ‘pos/tr’ denotes
the proportion of children in each country testing positive by Kato-Katz and trace by CCA. Note that the bar showing the
proportion of children negative on both tests (75% in Coˆte d’Ivoire and 76% in Uganda) has been removed from the graph
to enable easier comparison of non-negative results.
https://doi.org/10.1371/journal.pntd.0006102.g001
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Sensitivity of Kato-Katz in Coˆte d’Ivoire (59.9%) was significantly higher than in Uganda
(32.3%; Table 1, Fig 2), although, there was no evidence of sensitivity estimates of CCAtn and
CCAtp differing between the countries (CCAtn = 49.3% and 50.1%; CCAtp = 63.0% and
69.7% in Coˆte d’Ivoire and Uganda respectively). In both countries, the sensitivity of CCAtp
was significantly higher than the sensitivity of CCAtn. However, the countries differed with
respect to the patterns of differences between CCA and Kato-Katz. In Coˆte d’Ivoire, the sensi-
tivity of CCAtn was significantly lower than the sensitivity of Kato-Katz, but the sensitivity of
CCAtp was not significantly different from the sensitivity of Kato-Katz. In contrast, in Uganda,
the sensitivities of CCAtn and CCAtp were both higher than the sensitivity of Kato-Katz.
The estimated specificity of Kato-Katz did not differ significantly across the two countries
(99.0% in Coˆte d’Ivoire vs. 99.3% in Uganda; Table 1, Fig 2). There was no evidence that the
specificity of CCAtn differed between the countries (Coˆte d’Ivoire = 98.0%, Uganda = 98.8%),
but the estimated specificity of CCAtp in Coˆte d’Ivoire (91.0%) was marginally, non-signifi-
cantly, higher than in Uganda (87.6%; Table 2, Fig 2). In both countries, the estimated specific-
ity of CCAtp was significantly less than both the estimated specificity of CCAtn and the
estimated specificity of Kato-Katz. In Coˆte d’Ivoire, the estimated specificity of CCAtn was
marginally, non-significantly, less than the estimated specificity of Kato-Katz and there was no
evidence in Uganda that the estimated specificity of CCAtn and Kato-Katz differed.
Comparison between infection and test prevalence
Infection prevalence was estimated to be 20.5% in Coˆte d’Ivoire (Table 1; Fig 3) and 19.4% in
Uganda. Indeed, there was no evidence that the estimates of infection prevalence differed
between the countries (Table 2; Fig 3).
Both Kato-Katz and CCAtn substantially underestimated infection prevalence (Table 2; Fig
3). In contrast, there was no significant difference between test and infection prevalence by
CCAtp in either country, with the CCAtp prevalence falling within 0.4 percentage points of
the infection prevalence estimate in Coˆte d’Ivoire, and within 3.1 percentage points of the
infection prevalence estimate in Uganda.
Discussion
The aim of this study was to understand the implications considering CCA trace as negative or
positive using data from two countries, Coˆte d’Ivoire and Uganda. We particularly focused on
assessing the performance of CCA and Kato-Katz at measuring infection prevalence, as this is
the main purpose of S. mansoni diagnostics in the control programs. We found that the sensi-
tivities and specificities of CCA were much more consistent between countries than Kato-Katz
and that estimates of prevalence by CCA with trace as positive was not significantly different
from infection prevalence in either country. We discuss below possible reasons and implica-
tions for these results.
We found that trace values treated as positive (CCAtp) had significantly and substantially
higher sensitivity and lower specificity than when treated as negative (CCAtn) in both coun-
tries. However, the sensitivity estimates indicated that CCAtp still did not detect a substantial
proportion of infections (at least 30% in both countries), and this was supported by the raw
data where 35% and 24% of the children that were Kato-Katz positive in Coˆte d’Ivoire and
Uganda, respectively were negative by CCA. Although some of this may be due to misidentify-
ing of samples, it seems extraordinary that this could explain the entire pattern.
We used LCA to analyse the data, as there is no ‘gold standard’ test for S. mansoni infection.
We put a strong prior distribution (95% certain greater than 80%, with mode at 95%) on the
specificity of Kato-Katz which may partly explain why estimated specificity of Kato-Katz
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(99%) was high and did not differ between countries. However, the lower Bayesian 95% confi-
dence limit of Kato-Katz specificity was greater than the mode of the prior distribution sug-
gesting that the data were not indicating lower specificity of the Kato-Katz than the prior.
Table 2. Output from Bayesian LCA showing mean estimate and the 95% Bayesian credible interval. Sensitivity and specificity and infection preva-
lence were estimated from the model while all other parameters were estimated from these posterior distributions using the equations described in the meth-
ods. The column on the right shows the estimate of the difference between the Coˆte d’Ivoire and Uganda estimates.
Coˆte d’Ivoire Uganda Coˆte d’Ivoire - Uganda
Sensitivity
Kato-Katz 59.9% (53.6%, 65.7%) 32.3% (21.8%, 43.9%) 27.5% (14.2%, 39.8%)
CCAtn 49.3% (43.6%, 55.0%) 50.1% (36.2%, 65.1%) -0.8% (-17.0%, 14.1%)
CCAtp 63.0% (57.5%, 68.3%) 69.7% (56.4%, 82.0%) -6.7% (-20.3%, 7.4%)
CCAtn - Kato-Katz -10.5% (-17.0%, -4.1%) 17.8% (5.6%, 30.9%)
CCAtp - Kato-Katz 3.1% (-3.4%, 9.5%) 37.3% (24.5%, 49.7%)
CCAtp - CCAtn 13.7% (10.3%, 17.4%) 19.5% (10.2%, 30.0%)
Specificity
Kato-Katz 99.0% (98.2%, 99.7%) 99.3% (98.3%, 99.9%) -0.3% (-1.4%, 0.9%)
CCAtn 98.0% (97.1%, 98.7%) 98.8% (97.2%, 99.9%) -0.9% (-2.3%, 0.9%)
CCAtp 87.6% (83.9%, 91.1%) 91.0% (89.5%, 92.4%) 3.4% (-0.4%, 7.4%)
CCAtn - Kato-Katz -1.0% (-2.1%, 0.0%) -0.5% (-2.2%, 0.8%)
CCAtp - Kato-Katz -8.0% (-9.7%, -6.4%) -11.8% (-15.5%, -8.2%)
CCAtp - CCAtn -7.0% (-8.2%, -5.8%) -11.3% (-14.6%, -8.1%)
Infection prevalence
Infection prevalence 20.5% (18.4%, 22.9%) 19.4% (14.8%, 25.0%) 1.2% (-4.9%, 6.4%)
PPV
Kato-Katz 93.9% (89.0%, 98.3%) 92.1% (79.4%, 98.9%) 1.8% (-7.1%, 14.7%)
CCAtn 86.2% (80.5%, 91.3%) 91.1% (78.4%, 99.0%) -5.0% (-15.1%, 8.6%)
CCAtp 64.3% (58.9%, 70.0%) 57.2% (45.8%, 69.5%) 7.1% (-6.1%, 19.8%)
CCAtn - Kato-Katz -7.7% (-14.1%, -1.0%) -1.0% (-14.4%, 11.7%)
CCAtp - Kato-Katz -29.6% (-36.2%, -22.6%) -34.9% (-48.5%, -19.2%)
CCAtp - CCAtn -21.8% (-26.5%, -17.3%) -33.9% (-45.1%, -21.9%)
NPV
Kato-Katz 90.5% (88.1%, 92.6%) 85.8% (79.8%, 90.6%) 4.6% (-0.8%, 11.0%)
CCAtn 88.2% (85.7%, 90.3%) 89.1% (82.9%, 93.8%) -0.9% (-6.3%, 5.5%)
CCAtp 90.5% (88.2%, 92.4%) 92.2% (86.7%, 96.1%) -1.7% (-6.4%, 4.0%)
CCAtn - Kato-Katz -2.3% (-3.7%, -0.9%) 3.2% (0.9%, 5.5%)
CCAtp - Kato-Katz 0.0% (-1.5%, 1.5%) 6.4% (3.3%, 9.6%)
CCAtp - CCAtn 2.3% (1.5%, 3.2%) 3.1% (1.0%, 6.0%)
Test prevalence
Kato-Katz 13.4% (12.4%, 14.4%) 6.1% (4.5%, 7.6%) 7.3% (5.4%, 9.1%)
CCAtn 11.7% (10.7%, 12.7%) 9.7% (7.8%, 11.5%) 2% (-0.1%, 4.1%)
CCAtp 20.1% (18.8%, 21.4%) 22.5% (19.8%, 25.3%) -2.3% (-5.4%, 0.7%)
Comparison of prevalence estimates
Kato-Katz - infection prev -7.2% (-9.7%, -4.7%) -13.3% (-19.1%, -8.5%) 6.1% (0.6%, 12.5%)
CCAtn - infection prev -8.8% (-11.4%, -6.5%) -9.7% (-15.6%, -4.7%) 0.9% (-4.8%, 7.3%)
CCAtp - infection prev -0.4% (-3.2%, 2.1%) 3.1% (-3.3%, 8.4%) -3.5% (-9.5%, 3.2%)
CCAtn - Kato-Katz -1.7% (-3.1%, -0.3%) 3.6% (1.2%, 6.1%) -5.3% (-8.1%, -2.5%)
CCAtp - Kato-Katz 6.8% (5.2%, 8.3%) 16.4% (13.3%, 19.6%) -9.6% (-13.2%, -6.1%)
CCAtp - CCAtn 8.4% (6.8%, 10.1%) 12.8% (9.4%, 16.2%) -4.4% (-8.1%, -0.6%)
https://doi.org/10.1371/journal.pntd.0006102.t002
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Consequently, the use of Bayesian analysis enabled us to assess the appropriateness of our
assumptions, which would not be possible in a frequentist framework.
We elected to analyse trace positive and trace negative results within a single model. This
method of analysis can be applied to any diagnostic where the result is not binary, where the
results are in some way graded, and where alternative cut-off points can be assumed positive.
The analysis is simple to implement and extend, with the key being that increasing the number
of people testing positive on a sliding scale increases the sensitivity but decreases the specificity
of the test. The preferred sensitivity and specificity balance of a diagnostic will depend on a
number of different factors such as the properties of other diagnostics in use, the expected
prevalence in the test population, and cost considerations. An alternative way to approach the
Fig 2. Plots showing the posterior distributions of sensitivity (left) and specificity (right) of each test in
Coˆte d’Ivoire (blue) and Uganda (green) estimated from a Bayesian Latent Class Analysis. Note that the x-
axis for the specificity has been truncated to begin at 80% to enable easier comparison between tests.
https://doi.org/10.1371/journal.pntd.0006102.g002
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analysis would be to analyse CCA trace negative and trace positive results separately. However,
this risks the model returning logically impossible sensitivity estimates lower for trace positive
than trace negative, or specificity estimates higher for trace positive than trace negative. Fitting
trace positive and negative within a single model prevents this and also avoids having to inter-
pret multiple estimates for sensitivities and specificities of other tests, and also for infection
prevalence.
We analysed the data in a Bayesian framework, where the use of prior distributions can
help overcome issues around degrees of freedom while still letting the data indicate if the
assumptions made are not valid, as opposed to the absolute assumptions that can be required
in a frequentist framework. Bayesian analysis also outputs the full distribution of each parame-
ter through the iterations saved by the model. Consequently, distributions of additional vari-
ables calculated from the parameters are simple to obtain; we used this technique both to test
for significance of differences between terms and between studies and to compare test preva-
lence and infection prevalence for each test.
Comparing between studies, we found that the estimated sensitivity and specificity of both
CCAtp and CCAtn did not differ between the countries, in line with previous results that
found the performance of CCA to be consistent before and after treatment [13]. However, the
estimated sensitivity of Kato-Katz was much higher in Coˆte d’Ivoire, where the mean infection
intensity was also much higher, than in Uganda. Lower sensitivity of Kato-Katz at low infec-
tion intensities is a well-known issue [10] and it is possible that this is the reason for our find-
ings. A number of previous papers have assumed Kato-Katz to be the gold standard, including
in a recent Cochrane review [27]. It is clear from these, and many other results, that it is not
appropriate for Kato-Katz to be considered a gold standard, particularly at low intensities. We
Fig 3. Estimated infection prevalence and tests prevalence from each test in Coˆte d’Ivoire and Uganda obtained
from LCA.
https://doi.org/10.1371/journal.pntd.0006102.g003
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echo researchers in this [28] and other [29] fields in concluding that LCA is the most appropri-
ate tool for assessing test sensitivity and specificity in the absence of a gold standard.
Our work adds to a growing body of literature using LCA to assess the performance of
CCA [20, 30–35]. Our estimates of sensitivity for both CCA and Kato-Katz were on the lower
end of those observed in these other studies, and our specificity estimates for CCA were rela-
tively high. These studies together seem to be reflecting the general pattern of Kato-Katz sensi-
tivity being strongly associated with infection intensities, with CCA perhaps being more
consistent between environments [36]. However, this study is the first, to our knowledge, to
assess the performance of CCA with respect to its main use in control programs of estimating
prevalence within the study population.
Comparison of test and estimated infection prevalence suggested that the prevalence mea-
sured by CCAtp was not significantly different from infection prevalence in either country and
that both Kato-Katz and CCAtn significantly underestimated infection prevalence in both
countries. Consequently, our results imply that CCAtp is revealing substantial numbers of
children infected with S. mansoni that were not detectable by Kato-Katz [37]. Although it
could be argued that the infected children that are being missed by Kato-Katz are those with
the lowest infection intensities, even low levels of schistosomiasis have an associated morbidity
burden [38]. Interestingly, estimated infection prevalence did not differ between Coˆte d’Ivoire
and Uganda, despite Kato-Katz prevalence being more than twice as high in Coˆte d’Ivoire than
in Uganda. The difference in Kato-Katz prevalence was presumably due to repeated rounds of
treatment in Uganda leading to lower average infection intensities than in Coˆte d’Ivoire,
which are better detected by CCA than Kato-Katz. However, in the absence of historical Kato-
Katz and CCA data from the schools in Uganda, it is not possible to assess whether repeated
rounds of treatment in Uganda has also been associated with a concurrent decrease in esti-
mated prevalence.
The main weakness of this study is the reliance on only two tests. Additional tests would be
expected to increase the robustness of the study through increasing degrees of freedom, and
there is clearly a need for additional studies incorporating more tests. However, we tried to
mitigate for this weakness by using LCA, and also by incorporating covariances between the
tests, which is expected to lead to more robust estimates than simply assuming the properties
of different tests to be independent [39]. Additionally, the sample sizes in Coˆte d’Ivoire were
over 4-fold higher than in Uganda, which is likely reflected in the larger confidence intervals
around estimates from Uganda. As CCA becomes a more commonly used field tool, we expect
sample sizes available for analyses to also increase.
We demonstrated here how ambiguous trace results can be incorporated into LCA using S.
mansoni data from Coˆte d’Ivoire and Uganda, enabling direct comparison of test properties
when trace was considered both as negative and positive, and avoiding having to make
assumptions as to the nature of trace results. Our results suggested CCA with trace as positive
was most reflective of infection prevalence and that both Kato-Katz and CCA with trace as
negative substantially underestimated infection prevalence. Consequently, we conclude that
CCA is an appropriate tool for field testing for S. mansoni in control programmes.
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